News and Updates

Investment Reports: Interview with Avi Veidman

January 15, 2026

Nucleai and University of Glasgow Partner to Pioneer Multimodal Precision Medicine for Colorectal Cancer

November 12, 2025

AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients

November 4, 2025

Top 10 Spatial Biology Companies of 2025

October 8, 2025

Nucleai to Showcase Expanded Suite of ADC Biomarker Scoring Solutions at ASCO 2025

May 28, 2025

Beyond cell atlases: spatial biology reveals mechanisms behind disease

May 23, 2025

Nucleai Launches First-of-its-Kind Deep Learning Model to Automate Spatial Proteomics, Accelerating Biomarker Discovery for ADCs, Bispecifics, and

April 22, 2025

How AI and Spatial Biomarkers Are Transforming Antibody–Drug Conjugate Development

March 21, 2025

Nucleai Highlights AI-Powered Spatial Biomarker Breakthroughs to Enhance Immunotherapy Success for Lung and Skin Cancer Patients at

November 5, 2024

Top 10 Spatial Biology Companies of 2024

October 31, 2024

Targeting the Blast Radius: Why Spatial AI Diagnostics Are Crucial for Maximizing the Impact of Antibody-Drug Conjugates

October 25, 2024

How spatial AI is uncovering the hidden truths of breast cancer

October 21, 2024

Contact us

To request more information or to get a demo, quote for our products, please fill out the form below.

Unsubscribe at any time using the link in our emails.
For details, see our Privacy Policy.